Clinical Trial Record

Return to Clinical Trials

Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer


2016-11-14


2020-10-19


2020-10-19


8

Study Overview

Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer

This pilot research trial studies characterization of mechanical tissue properties in patients with pancreatic, liver, or colon cancer. Mechanical properties and stiffness of the cancerous tissue may be correlated with the standard pathology report that describes the stage of the disease.

PRIMARY OBJECTIVES: I. To determine if our optical polarimeter device is able to measure tissue stiffness across several human cancer types ex vivo. SECONDARY OBJECTIVES: I. To describe the inter- and intra-tumor heterogeneity of tissue stiffness. II. To determine if the measurements made by the optical polarimeter device are non-destructive. TERTIARY OBJECTIVES: I. Perform multi-variable cross-correlation statistical analysis to determine relationships between: tissue stiffness characteristics, molecular level signatures, and cellular level properties, and if numbers permit, response to treatment. OUTLINE: Patients undergo fresh tumor tissue collection at the time of surgery. The fresh tumor tissue samples are analyzed for tissue stiffness measurements using an optical polarimeter device and cell viability using an automated cell counter.

  • Colon Carcinoma
  • Liver and Intrahepatic Bile Duct Carcinoma
  • Pancreatic Carcinoma
  • PROCEDURE: Biospecimen Collection
  • OTHER: Laboratory Biomarker Analysis
  • OTHER: Laboratory Procedure
  • 0S-16-1
  • NCI-2016-01955 (REGISTRY Identifier) (REGISTRY: CTRP (Clinical Trial Reporting Program))
  • 0S-16-1 (OTHER Identifier) (OTHER: USC / Norris Comprehensive Cancer Center)
  • P30CA014089 (U.S. NIH Grant/Contract)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2017-04-29  

N/A  

2021-04-01  

2017-04-29  

N/A  

2021-04-05  

2017-05-03  

N/A  

2021-04  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
: Ancillary-correlative (tissue stiffness analysis)

Patients undergo fresh tumor tissue collection at the time of surgery. The fresh tumor tissue samples are analyzed for tissue stiffness measurements using optical polarimeter device and cell viability using automated cell counter.

PROCEDURE: Biospecimen Collection

  • Undergo fresh tumor tissue collection

OTHER: Laboratory Biomarker Analysis

  • Correlative studies

OTHER: Laboratory Procedure

  • Tissue stiffness and cell viability analysis
Primary Outcome MeasuresMeasure DescriptionTime Frame
Young's modulus (stiffness) on fresh tissueA portable optical fiber polarimetric sensor device to measure the Young's modulus in tissue samples will be used.Up to 15 months
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Scheduled for surgery to remove primary tumors in the pancreas, liver or colon and have not undergone any prior treatment
  • Ability to understand and the willingness to sign a written informed consent

  • Exclusion Criteria:

  • Pregnant women will not be consented
  • Patients that are unable to consent for surgery
  • Primary liver tumors with cirrhosis will be excluded from this study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • National Cancer Institute (NCI)

  • PRINCIPAL_INVESTIGATOR: Shannon Mumenthaler, Ph.D., University of Southern California

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available